Author

MT Barrett

Institutions: Mayo Clinic in Arizona, Arizona State University

Observed institutions: Translational Genomics Research Institute, Merck & Co., Inc., Rahway, NJ, USA (United States), Mayo Clinic, Agilent Technologies (United States), Tianjin Medical University Cancer Institute and Hospital, Mayo Clinic in Arizona, Mayo Clinic Hospital, Mayo Clinic in Florida, Arizona State University, Tianjin Medical University, University of Otago

OpenAlex ID: A5000278990

Abstract P6-03-13: The genomic landscape of PD-L1, PD-L2, Jak2 (PDJ) amplified triple negative breast carcinoma

2016 · CD Gawryletz, KS Anderson, et al. · Cancer Research · 2

Abstract P5-04-19: JAK2 copy number and targeted JAK2 inhibition of TNBC cell lines

2016 · M Chen, M Andreozzi, et al. · Cancer Research · 1

Abstract P2-07-05: Genomic lesions and PD-1/PD-L1 expression in resected triple negative breast cancers

2018 · MT Barrett, E Lenkiewicz, et al. · Cancer Research

Abstract P1-05-12: Clonal heterogeneity in breast cancer and its impact on clinical biomarkers

2017 · MT Barrett, E Lenkiewicz, et al. · Cancer Research

Abstract P6-07-17: A novel fluorescence in situ hybridization assay to detect 9p24.1 amplification in triple negative breast cancer

2017 · M Chen, M Andreozzi, et al. · Cancer Research

Abstract P2-04-18: JAK2 and PD-L1 amplification enhance the dynamic expression of PD-L1 in triple negative breast cancer

2017 · M Chen, B Pockaj, et al. · Cancer Research

Abstract PD5-03: Effect of PD-1 and PD-L1 in the tumor microenvironment on overall survival of triple-negative breast cancer patients

2017 · ME Linnaus, H Kosiorek, et al. · Cancer Research

Abstract P1-05-19: Homologous recombination deficiency in PD-L1, PD-L2, Jak2 (PDJ) amplified triple negative breast carcinoma

2017 · CD Gawryletz, KS Anderson, et al. · Cancer Research

Abstract P1-03-13: Immunohistochemistry cannot be used to detect PD-L1/JAK-2 amplification

2017 · ME Linnaus, H Kosiorek, et al. · Cancer Research

Abstract P4-04-02: Amplification of chromosome 9p24 targeting PD-L1 and JAK2 correlates with altered tumor microenvironment expression profiles in triple negative breast cancer

2016 · KS Anderson, M Andreozzi, et al. · Cancer Research

Abstract PD4-7: Deep clonal profiling of primary breast cancer and distant lymph node metastases

2013 · P Francis, E Lenkiewicz, et al. · Cancer Research

Comparative genomic hybridization using oligonucleotide arrays and total genomic DNA

2005 · MT Barrett, N Sampas, et al. · Breast Cancer Research

Works count: 12

Citation count: 3

H-index: 1

I10-index: